Evidence map›Paper›PMID 33859526›Full record

ArticleInternational journal of medical sciences2021

Para-chloro-2-[

Isabella Silins, Anders Sundin, Patrik Nordeman, Mahabuba Jahan, Sergio Estrada, Azita Monazzam, Mark Lubberink, Franklin Aigbirhio, Per Hellman, Gunnar Antoni

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06616142 (Para-chloro-2-[18F]Fluoroethyl-etomidate), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06616142 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Para-chloro-2-[18F]Fluoroethyl-etomidate ([18F]CETO) as a New PET-tracer for Subtyping in Patients With Primary Aldosteronism - a Pilot Study

TypeinterventionalSponsorUniversity Medical Center GroningenRan2024 to 2027Enrolled12ConditionsPrimary AldosteronismArms[18F]CETO tracer, Dexamethasone oral, Adrenal vein sampling
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. [Nature medicine · 2023
    Trial
  2. Review
  3. Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging.The Journal of clinical endocrinology and metabolism · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Isabella SilinsDepartment of Surgical Sciences, Uppsala University.
Anders SundinDepartment of Surgical Sciences, Uppsala University.
Patrik NordemanMedicinal Chemistry and Uppsala University.
Mahabuba JahanMedicinal Chemistry and Uppsala University.
Sergio EstradaMedicinal Chemistry and Uppsala University.
Azita MonazzamMedical Sciences at Uppsala University.
Mark LubberinkDepartment of Surgical Sciences, Uppsala University.
Franklin AigbirhioWolfson Brain Imaging Centre, University of Cambridge.
Per HellmanDepartment of Surgical Sciences, Uppsala University.
Gunnar AntoniMedicinal Chemistry and Uppsala University.
Uppsala University · SEUniversity of Cambridge · GB

Funding

Medical Research Council MR/M009041/1Medical Research Council MR/P01710X/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenal CortexAdrenal Cortex NeoplasmsAnimalsDrug Evaluation, PreclinicalEtomidateFluorine RadioisotopesHumansHyperaldosteronismMacaca fascicularisMicePositron-Emission TomographyRadiopharmaceuticalsRatsTissue DistributionEtomidateFluorine-18Fluorine RadioisotopesRadiopharmaceuticals18F-CETOAdrenal massesAdrenal tracerPositron emission tomographyPrimary aldosteronism

Identifiers

PMID33859526
PMCPMC8040415
OpenAlexW3156394258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.